In summary, YAP nuclear localization is highly prevalent in thyroid cancer, not associated with upstream canonical HIPPO pathway gene alterations and co-occurs with BRAF and RAS mutations. This evidence concerns the gene YAP1 and thyroid gland carcinoma.